Antibacterial Effect of Silver Nanoparticles along with L-Arginine against P. aeruginosa
Author(s) -
Mina Parsa,
Malahat Ahmadi,
Habib Dastmalchı Saeı,
Aliasghar Tehrani
Publication year - 2017
Publication title -
medical laboratory journal
Language(s) - English
Resource type - Journals
ISSN - 2538-4449
DOI - 10.29252/mlj.11.6.7
Subject(s) - pseudomonas aeruginosa , arginine , minimum inhibitory concentration , silver nanoparticle , chemistry , antimicrobial , microbiology and biotechnology , antibacterial activity , pharmacology , bacteria , medicine , nanoparticle , biology , biochemistry , nanotechnology , amino acid , materials science , genetics
Background and Objectives: Nowadays, the prevalence of multidrug-resistant pathogens such as Pseudomonas aeruginosa is increasing worldwide. Many studies have been seeking new treatment strategies to treat infections caused by these microorganisms. Silver nanoparticles (AgNPs) along with L-arginine have significant antimicrobial effects and could be used as alternatives for ineffective drugs. Methods: In this study, the antibacterial activity of AgNPs, L-arginine and various concentrations of AgNPs along with L-arginine (12.5 and 25 mg/ml) were investigated against P. aeruginosa PAO1 using the broth macrodilution method. Results: Minimum inhibitory concentration of AgNPs, L-arginine and AgNPs combined with 25 and 12.5 mg/ml L-arginine was 15.6 μg/ml, 25 mg/ml, 1.9 μg/ml and 3.9 μg/ml, respectively. Minimum bactericidal concentration of AgNPs, L-arginine and AgNPs combined with 25 and 12.5 mg/ml L-arginine was 31.2 μg/ml, 50 mg/ml, 3.9 μg/ml and 7.8 μg/ml,
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom